Point72 Asset Management
CAMP icon

Point72 Asset Management’s CAMP4 Therapeutics CAMP Stock Holding History

Point72 Asset Management’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,326
Closed -$76.4K – 4055
2026
Q1 		$76.4K Buy
+17,326
New +$82.2K ﹤0.01% 3639

Other funds holding CAMP

Jupiter Topco
Jupiter Topco New York $245B AUM
5AM Venture Management
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
AH Capital Management
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Trails Edge Capital Partners
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management's CAMP Position: Q2 2026 in Review

Point72 Asset Management sold out of CAMP4 Therapeutics (CAMP) in Q2 2026, closing a stake of 17,326 shares — an estimated $76.4K sold.

Point72 Asset Management first reported a position in CAMP in Q1 2026 and held it in 1 quarter. The position peaked at $76.4K in Q1 2026. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Point72 Asset Management reported no remaining CAMP4 Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 17,326 CAMP4 Therapeutics shares in Q2 2026, an estimated $76.4K.
  • Point72 Asset Management first reported a position in CAMP4 Therapeutics in Q1 2026 and held it in 1 quarter.
  • Point72 Asset Management's CAMP4 Therapeutics position peaked at $76.4K in Q1 2026.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.